more general categories |
information about this item |
|
1. Human Genes |
 |
 |
|
1. Human Genes |
|
|
cytochrome P450, family 02, subfamily E, polypeptide 01 [HGNC:CYP2E1] (225) |
|
 |
2. Interaction: Human Genes and Chemicals |
 |
 |
|
2. Interaction: Human Genes and Chemicals |
|
|
oxidation (295) |
|
 |
C01. Bacterial Infections and Mycoses |
 |
 |
|
C01. Bacterial Infections and Mycoses |
|
|
|
|
|
|
|
|
Endotoxemia [MESH:D019446] (1289) |
|
|
Endotoxemia [MESH:D019446] (1289) |
|
 |
C04. Neoplasms |
 |
 |
|
C04. Neoplasms |
|
|
|
|
|
|
|
|
Lymphoma, Non-Hodgkin [MESH:D008228] (3337) |
|
|
|
|
|
|
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
|
|
|
|
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
 |
C06. Digestive System Diseases |
 |
 |
|
C06. Digestive System Diseases |
|
|
|
|
|
|
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Fatty Liver [MESH:D005234] (3584) |
|
|
Hepatitis [MESH:D006505] (3883) |
|
|
Liver Cirrhosis, Alcoholic [MESH:D008104] (3066) |
|
|
Liver Cirrhosis, Experimental [MESH:D008106] (4589) |
|
|
Liver Cirrhosis, Alcoholic [MESH:D008104] (3066) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
 |
C08. Respiratory Tract Diseases |
 |
 |
|
C08. Respiratory Tract Diseases |
|
|
|
|
|
|
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
|
|
|
|
|
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
 |
C10. Nervous System Diseases |
 |
 |
|
C10. Nervous System Diseases |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parkinson Disease [MESH:D010300] (3595) |
|
|
|
|
|
|
|
|
Ornithine Carbamoyltransferase Deficiency Disease [MESH:D020163] (56) |
|
|
|
|
|
Parkinson Disease [MESH:D010300] (3595) |
|
|
Parkinson Disease [MESH:D010300] (3595) |
|
 |
C12. Male Urogenital Diseases |
 |
 |
|
C12. Male Urogenital Diseases |
|
|
|
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
Oligospermia [MESH:D009845] (799) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
Renal Insufficiency [MESH:D051437] (4951) |
|
 |
C13. Female Urogenital Diseases and Pregnancy Complications |
 |
 |
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
|
|
|
|
|
|
Renal Insufficiency [MESH:D051437] (4951) |
|
 |
C14. Cardiovascular Diseases |
 |
 |
|
C14. Cardiovascular Diseases |
|
|
|
|
|
Cardiomegaly [MESH:D006332] (4081) |
|
 |
C15. Hemic and Lymphatic Diseases |
 |
 |
|
C15. Hemic and Lymphatic Diseases |
|
|
|
|
|
Anemia, Hemolytic [MESH:D000743] (3083) |
|
|
Disseminated Intravascular Coagulation [MESH:D004211] (462) |
|
|
Disseminated Intravascular Coagulation [MESH:D004211] (462) |
|
|
Disseminated Intravascular Coagulation [MESH:D004211] (462) |
|
|
|
|
|
|
|
|
Lymphoma, Non-Hodgkin [MESH:D008228] (3330) |
|
 |
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
 |
 |
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
|
|
|
|
|
|
|
|
Ornithine Carbamoyltransferase Deficiency Disease [MESH:D020163] (56) |
|
|
|
|
|
|
|
|
Ornithine Carbamoyltransferase Deficiency Disease [MESH:D020163] (56) |
|
|
|
|
|
Ornithine Carbamoyltransferase Deficiency Disease [MESH:D020163] (56) |
|
|
Lipidoses [MESH:D008064] (1655) |
|
 |
C17. Skin and Connective Tissue Diseases |
 |
 |
|
C17. Skin and Connective Tissue Diseases |
|
|
|
|
|
Dermatitis, Contact [MESH:D003877] (3394) |
|
|
Drug Eruptions [MESH:D003875] (2697) |
|
|
Dermatitis, Contact [MESH:D003877] (3394) |
|
 |
C18. Nutritional and Metabolic Diseases |
 |
 |
|
C18. Nutritional and Metabolic Diseases |
|
|
|
|
|
|
|
|
|
|
|
Ornithine Carbamoyltransferase Deficiency Disease [MESH:D020163] (56) |
|
|
|
|
|
Hemosiderosis [MESH:D006486] (38) |
|
|
Lipidoses [MESH:D008064] (1655) |
|
|
|
|
|
|
|
|
Ornithine Carbamoyltransferase Deficiency Disease [MESH:D020163] (56) |
|
|
|
|
|
Ornithine Carbamoyltransferase Deficiency Disease [MESH:D020163] (56) |
|
|
Lipidoses [MESH:D008064] (1655) |
|
 |
C20. Immune System Diseases |
 |
 |
|
C20. Immune System Diseases |
|
|
|
|
|
|
|
|
Drug Eruptions [MESH:D003875] (2695) |
|
|
|
|
|
|
|
|
Lymphoma, Non-Hodgkin [MESH:D008228] (3330) |
|
 |
C23. Pathological Conditions, Signs and Symptoms |
 |
 |
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
|
|
|
Cardiomegaly [MESH:D006332] (3802) |
|
|
Hemolysis [MESH:D006461] (280) |
|
|
Hyperammonemia [MESH:D022124] (322) |
|
|
Hyperbilirubinemia [MESH:D006932] (1860) |
|
|
Necrosis [MESH:D009336] (4019) |
|
|
Micronuclei, Chromosome-Defective [MESH:D048629] (1013) |
|
|
|
|
|
|
|
|
|
|
|
Endotoxemia [MESH:D019446] (1289) |
|
 |
C25. Chemically-Induced Disorders |
 |
 |
|
C25. Chemically-Induced Disorders |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Drug Eruptions [MESH:D003875] (2697) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
|
|
|
Alcoholism [MESH:D000437] (1519) |
|
|
|
|
|
Liver Cirrhosis, Alcoholic [MESH:D008104] (3066) |
|
 |
D02. Organic Chemicals |
 |
 |
|
D02. Organic Chemicals |
|
|
|
|
|
|
|
|
|
|
|
Propane [MESH:D011407] (110) |
|
 |